Related Articles
BRMS1 participates in regulating cell sensitivity to DNA interstrand crosslink damage by interacting with FANCI
Characterization of DAPK1 as a novel transcriptional target of BRMS1
Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells
Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells